874013-98-6 Usage
Molecular Weight
207.67 g/mol The molecular weight is the mass of one mole of the compound, calculated by adding the atomic weights of all the atoms in the molecular formula.
Structure
1H-Pyrrolo[2,3-c]pyridine core with a chlorine atom at the 7th position and two methyl groups at the 2nd and 3rd positions The structure refers to the arrangement of atoms in the compound, with the pyrrolopyridine core being the central feature and the chlorine and methyl groups attached to it.
Category
Pyrrolopyridine derivatives The compound belongs to a class of chemical compounds called pyrrolopyridine derivatives, which are known for their potential applications in medicinal chemistry and pharmaceutical research.
Potential Applications
Medicinal chemistry and pharmaceutical research The compound has potential applications in the field of medicinal chemistry and pharmaceutical research due to its unique structure and properties, which may possess biological activities that make it suitable for drug development.
Heterocyclic compound
A compound that contains at least one ring structure with at least one heteroatom The compound is a heterocyclic compound, which means it has at least one ring structure with at least one heteroatom (an atom other than carbon) in the ring.
Check Digit Verification of cas no
The CAS Registry Mumber 874013-98-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,7,4,0,1 and 3 respectively; the second part has 2 digits, 9 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 874013-98:
(8*8)+(7*7)+(6*4)+(5*0)+(4*1)+(3*3)+(2*9)+(1*8)=176
176 % 10 = 6
So 874013-98-6 is a valid CAS Registry Number.
874013-98-6Relevant articles and documents
Molecular modeling, design, synthesis, and biological activity of 1H-pyrrolo[2,3-c]pyridine-7-amine derivatives as potassium-competitive acid blockers
Arikawa, Yasuyoshi,Hasuoka, Atsushi,Hirase, Keizo,Inatomi, Nobuhiro,Sato, Fumihiko,Hori, Yasunobu,Takagi, Terufumi,Tarui, Naoki,Kawamoto, Makiko,Kajino, Masahiro
, p. 336 - 342 (2014/04/17)
A series of 1H-pyrrolo[2,3-c]pyridine-7-amine derivatives were designed and synthesized based on our docking model as potassium-competitive acid blockers (P-CABs). Molecular modeling of these derivatives led us to introduce a substituent at the 1-position
A COMPOSITION FOR TREATING OR PREVENTING A CANCER COMPRISING PYRROLOPYRIDINE DERIVATIVES
-
Page/Page column 36; 37, (2010/11/25)
The present invention provides a composition for treating or preventing a cancer comprising a pyrrolopyridine derivative or its salt and a pharmaceutically acceptable carrier.
